Skip to main content
. 2023 Oct 16;6(1):100931. doi: 10.1016/j.jhepr.2023.100931

Fig. 1.

Fig. 1

Regions contributing to the PBC audit and location of specialist centres in England.

Choropleth map indicating (A) the number of participants contributed by region, and (B) the location of regional specialist centres in England responsible for prescribing second-line treatment. SLT, second-line therapy; UDCA, ursodeoxycholic acid.